34 studies found for:    pkd
Show Display Options
Rank Status Study
1 Active, not recruiting HALT Progression of Polycystic Kidney Disease (HALT PKD) Study B
Condition: Kidney, Polycystic
Interventions: Drug: Lisinopril and Placebo;   Drug: Lisinopril and Telmisartan
2 Not yet recruiting Clinical and Molecular Description of PKD1 and PKD2 Mutation Negative Carriers in ADPKD
Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Intervention: Other: Blood Collection
3 Recruiting Pyruvate Kinase Deficiency Natural History Study
Conditions: Pyruvate Kinase Deficiency;   Congenital Non-Spherocytic Hemolytic Anemia
Intervention:
4 Recruiting PKD Clinical and Translational Core Study
Condition: Polycystic Kidney Disease
Intervention:
5 Unknown  UAB Recessive PKD Research and Translational Core Center
Condition: Autosomal Recessive Polycystic Kidney Disease
Intervention:
6 Recruiting LRRK2 Mutation and Parkinson's Disease
Condition: Parkinson Disease
Interventions: Genetic: Healthy;   Genetic: PKD Patients
7 Recruiting Pharmacogenomic Study on PKD/PKC of Dabigatran Etexilate and Rivaroxaban
Condition: Healthy Volunteers
Interventions: Drug: D->R->C+R;   Drug: D->R->C+D;   Drug: R->D->C+D;   Drug: R->D->C+R
8 Active, not recruiting HALT Progression of Polycystic Kidney Disease (HALT PKD) Study A
Condition: Kidney, Polycystic
Interventions: Drug: Lisinopril and Placebo;   Drug: Lisinopril and Telmisartan
9 Recruiting Polycystic Kidney Disease Data Repository
Condition: Polycystic Kidney Disease
Intervention:
10 Completed Efficacy Study of Water Drinking on PKD Progression.
Conditions: Autosomal Dominant Polycystic Kidney Disease.;   Disease Progression
Intervention:
11 Enrolling by invitation ADPKD Cohort Study
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention:
12 Unknown  High Water Intake to Slow Progression of Polycystic Kidney Disease
Condition: Kidney, Polycystic, Autosomal Dominant
Intervention: Other: Water
13 Completed Sirolimus Treatment in Patients With Autosomal Dominant Polycystic Kidney Disease: Renal Efficacy and Safety
Condition: Polycystic Kidney
Interventions: Drug: Sirolimus;   Drug: conventional therapy
14 Terminated Safety Study of SGX523, a Small Molecule Met Inhibitor, to Treat Solid Tumors
Condition: Advanced Cancer
Intervention: Drug: SGX523 Capsules
15 Recruiting Repository Study of Autosomal Dominant Polycystic Kidney Disease
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention:
16 Completed Water as Therapy in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention: Other: Water prescription
17 Recruiting UAB HRFD Core Center: Core A: The Hepato/Renal Fibrocystic Diseases Translational Resource
Conditions: Hepato/Renal Fibrocystic Disease;   Autosomal Recessive Polycystic Kidney Disease;   Joubert Syndrome;   Bardet Biedl Syndrome;   Meckel-Gruber Syndrome;   Congenital Hepatic Fibrosis;   Caroli Syndrome;   Oro-Facial-Digital Syndrome Type I;   Nephronophthisis;   Glomerulocystic Kidney Disease
Intervention:
18 Active, not recruiting A New Diet for Patients With Autosomal Dominant Polycystic Disease (ADPKD)
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention: Other: ADPKD Diet
19 Completed 8-Week Study of Tolvaptan Dose Forms in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Condition: Autosomal Dominant Polycystic Kidney Disease
Interventions: Drug: Tolvaptan MR;   Drug: Tolvaptan IR;   Drug: Placebo
20 Unknown  Clinical Trial to Slow the Progression of ADPKD
Conditions: Kidney, Polycystic;   Kidney, Polycystic, Autosomal Dominant
Intervention: Drug: anti-hypertensive medications

Previous Page Studies Shown (1-20) Next Page (21-34) Show next page of results
Indicates status has not been verified in more than two years